Some of the most widely used treatments for irritable bowel syndrome may be doing more harm than patients realize. A large-scale study analyzing data from over 600,000 individuals found that people with IBS who used antidepressants had a significantly higher risk of death compared to those who did not.
Antidepressants are frequently prescribed off-label for IBS to help manage pain and gut-brain signaling. But the findings raise serious concerns. Researchers observed that the longer these drugs were used, the higher the associated risk, with repeated prescriptions linked to a steady increase in mortality. Other issues, including higher rates of cardiovascular problems, obesity, and suicidal thoughts, were also more common among users.
While the study does not prove these drugs directly cause these outcomes, the pattern is difficult to ignore. For a condition as common as IBS, relying on medications that may carry long-term risks could come at a cost. These findings highlight the need to question routine prescribing and consider safer, more root-cause approaches to managing gut health
SOURCE:
News Medical, April 13, 2026